LISATA THERAPEUTICS, INC. Repayments of Secured Debt
LISATA THERAPEUTICS, INC. (LSTA) reported Repayments of Secured Debt of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSecuredDebt · last filed 2016-03-15
- LISATA THERAPEUTICS, INC. repayments of secured debt for the quarter ending 2015-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. repayments of secured debt for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. repayments of secured debt for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. repayments of secured debt for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. repayments of secured debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- LISATA THERAPEUTICS, INC. repayments of secured debt for fiscal 2014 was $3.24M, a 1504.29% increase from fiscal 2013.
- LISATA THERAPEUTICS, INC. repayments of secured debt for fiscal 2013 was $201.75K, a 2.63% increase from fiscal 2012.
- LISATA THERAPEUTICS, INC. repayments of secured debt for fiscal 2012 was $196.59K, a 31.46% increase from fiscal 2011.
| Period end | Repayments of Secured Debt 3 month | Repayments of Secured Debt 6 month | Repayments of Secured Debt 9 month | Repayments of Secured Debt 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $3.13M derived: sum of 4 quarters · filed 2016-03-15 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-06 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $3.13M derived: sum of 3 quarters · filed 2016-03-15 | $3.18M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $3.13M derived: sum of 2 quarters · filed 2016-03-15 | $3.18M derived: sum of 3 quarters · filed 2016-03-15 | $3.24M 10-K · filed 2016-03-15 |
| 2014-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $3.18M derived: sum of 2 quarters · filed 2015-11-05 | $3.24M 10-Q · filed 2015-11-05 | $3.29M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $52.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $105.45K 10-Q · filed 2015-08-06 | $156.91K derived: sum of 3 quarters · filed 2016-03-15 | $214.13K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $52.77K 10-Q · filed 2015-05-06 | $104.23K derived: sum of 2 quarters · filed 2016-03-15 | $161.45K derived: sum of 3 quarters · filed 2016-03-15 | $211.08K derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $51.46K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $108.68K derived: sum of 2 quarters · filed 2016-03-15 | $158.31K derived: sum of 3 quarters · filed 2016-03-15 | $201.75K 10-K · filed 2016-03-15 |
| 2013-09-30 | $57.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $106.85K derived: sum of 2 quarters · filed 2014-10-30 | $150.29K 10-Q · filed 2014-10-30 | $205.53K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $49.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $93.07K 10-Q · filed 2014-08-07 | $148.30K derived: sum of 3 quarters · filed 2015-03-02 | $195.90K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $43.45K 10-Q · filed 2014-05-08 | $98.68K derived: sum of 2 quarters · filed 2015-03-02 | $146.28K derived: sum of 3 quarters · filed 2015-03-02 | $187.04K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $55.23K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $102.83K derived: sum of 2 quarters · filed 2015-03-02 | $143.60K derived: sum of 3 quarters · filed 2015-03-02 | $196.59K 10-K · filed 2015-03-02 |
| 2012-09-30 | $47.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $88.36K derived: sum of 2 quarters · filed 2013-11-07 | $141.35K 10-Q · filed 2013-11-07 | $181.40K derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-06-30 | $40.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $93.75K 10-Q · filed 2013-08-08 | $133.81K derived: sum of 3 quarters · filed 2013-08-08 | $178.93K derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | $52.99K 10-Q · filed 2013-05-09 | $93.04K derived: sum of 2 quarters · filed 2013-05-09 | $138.16K derived: sum of 3 quarters · filed 2013-05-09 | $200.21K derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $40.05K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $85.18K derived: sum of 2 quarters · filed 2013-03-11 | $147.22K derived: sum of 3 quarters · filed 2013-03-11 | $149.54K 10-K · filed 2013-03-11 |
| 2011-09-30 | $45.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $107.17K derived: sum of 2 quarters · filed 2012-11-13 | $109.49K 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $62.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $64.37K 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | $2.32K 10-Q · filed 2012-05-11 | |||
| 2010-12-31 | $0.00 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |